Question 1

What are the most cited papers from GlycaNova (Norway)?

Accepted Answer

The most cited paper from GlycaNova (Norway) is "Supplementation with a Soluble Beta-Glucan Exported from Shiitake Medicinal Mushroom, Lentinus edodes (Berk.) Singer Mycelium: a Crossover, Placebo-Controlled Study in Healthy Elderly" (Jean‐Michel Gaullier, Jowita Sleboda, Erik Snorre Ofjord et al., 2011), with 46 citations. Next come "A Quality-of-Life Study in Healthy Adults Supplemented with Lentinex® Beta-Glucan of Shiitake Culinary-Medicinal Mushroom, Lentinus edodes (Agaricomycetes)" (6) and "The Positive Effects of Proprietary Undenatured β-Glucans on Stressed Marine Life" (2).

Question 2

Which research topics does GlycaNova (Norway) publish most on?

Accepted Answer

By volume in 2022-now: Aquaculture Nutrition and Growth, Aquaculture disease management and microbiota, Fungal Biology and Applications and Phytochemistry and Bioactivity Studies.

Question 3

Which fields of science does GlycaNova (Norway) work in?

Accepted Answer

In all years, 61% of research at GlycaNova (Norway) is in Life Sciences, 33% in Health Sciences. Its largest fields are Medicine (31%), Agricultural and Biological Sciences (22%), Biochemistry, Genetics and Molecular Biology (17%). It does 1.5× the world's share of Life Sciences.

Question 4

Is GlycaNova (Norway)'s research output growing?

Accepted Answer

Output in 2022-2025 was 200% higher than in 2018-2021.